Novo Nordisk, Inc.
US affiliate of a global pharmaceutical company focused on development, manufacture and commercialization of protein- and peptide-based therapeutics for diabetes, obesity, cardiometabolic and rare disease areas. Operates clinical development, medical affairs, regulatory and safety functions in the US, large-scale biologics manufacturing and supply chain operations, patient education and access programs, market access and payer engagement, and corporate ethics and compliance activities.
Industries
N/A
Products
Therapeutic portfolio for diabetes, obesity, cardiometabolic and rare diseases
A portfolio of protein- and peptide-based therapeutic programs and marketed medicines targeting diabetes, obesity, cardiometabolic conditions and selected rare diseases, supported by delivery systems and patient programs.
Therapeutic portfolio for diabetes, obesity, cardiometabolic and rare diseases
A portfolio of protein- and peptide-based therapeutic programs and marketed medicines targeting diabetes, obesity, cardiometabolic conditions and selected rare diseases, supported by delivery systems and patient programs.
Services
Medical publication support and review
Support for manuscripts and publications including third-party medical writing, ICMJE/GPP compliance and a required medical accuracy review prior to journal submission.
Patient education and access programs
Disease-specific education resources, affordability support and digital tools aimed at improving patient understanding and access to therapies, including language-specific chatbot support.
Supplier diversity and vendor registration
Supplier diversity program and online registration for minority-owned and small businesses, including self-certification requirements.
Clinical trial partnership and site engagement
Collaboration with clinical sites and investigators to support trial enrollment, with emphasis on sites that engage diverse patient populations.
Market access and payer contracting services
National payer engagement, pricing strategy and contract management to support patient access and commercial launch activities.
Medical publication support and review
Support for manuscripts and publications including third-party medical writing, ICMJE/GPP compliance and a required medical accuracy review prior to journal submission.
Patient education and access programs
Disease-specific education resources, affordability support and digital tools aimed at improving patient understanding and access to therapies, including language-specific chatbot support.
Supplier diversity and vendor registration
Supplier diversity program and online registration for minority-owned and small businesses, including self-certification requirements.
Clinical trial partnership and site engagement
Collaboration with clinical sites and investigators to support trial enrollment, with emphasis on sites that engage diverse patient populations.
Market access and payer contracting services
National payer engagement, pricing strategy and contract management to support patient access and commercial launch activities.
Expertise Areas
- Clinical trial management and diversity inclusion
- Bioprocessing and large-scale biologics manufacturing
- Protein- and peptide-therapeutic development
- Drug delivery system engineering
Key Technologies
- Fermentation-based bioprocessing
- Recombinant yeast expression systems
- Protein and peptide therapeutics
- Injection device delivery systems